Pathways to Entrepreneurship: Alexis Borisy ‘95
Exciting opportunities bridge academia and entrepreneurship; hear alumni discuss their individual journeys from training to careers in industry. Speakers will offer unique perspectives on how a solid educational and research foundation can act as a springboard to making global impact in the public sector.
Alexis Borisy joined Third Rock Ventures in 2009 and is an integral member of the Third Rock team and a successful company builder with more than 20 years of experience launching and operating innovative science-based organizations. Alexis focuses on the formation, development and strategy of new companies, with a particular focus in personalized medicine. He has played key roles in launching and building several portfolio companies:
- Interim CEO and board member at Blueprint Medicines
- Board member at Editas Medicine
- Chairman of the board and former interim CEO at Warp Drive Bio
- Co-founder, former interim CEO and chairman of the board at Foundation Medicine
Prior to joining Third Rock Ventures, Alexis founded CombinatoRx in 2000, serving as its chief executive officer and bringing the company public on NASDAQ just five years later. He has raised more than $1 billion in financing and business development deals, and has authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard University, where he was a Howard Hughes Predoctoral Fellow, Alexis was honored as the Massachusetts Institute of Technology Technology Review Innovator of the Year in 2003. He was also chosen as the New England Entrepreneur of the Year in Life Sciences in 2003 and was honored as a Presidential Scholar in 1989. Alexis holds a B.S. in chemistry from the University of Chicago, and completed his graduate work in the laboratory of Dr. Stuart Schreiber at Harvard. Alexis serves on the board of the Biotechnology Industry Organization and is an overseer at the Boston Museum of Science.